Ovarian remnant syndrome (ORS) is not immediately life-threatening, but it can cause significant problems if left untreated. The condition occurs when functional ovarian tissue is accidentally left behind after surgical removal of both ovaries. That tissue continues producing hormones, can form painful masses, and in rare cases may develop malignancy. The level of danger depends largely on whether the remnant is growing, pressing on nearby organs, or undergoing cancerous changes.
What Ovarian Remnant Syndrome Actually Is
ORS develops in women who have had both ovaries surgically removed, with or without a hysterectomy. Small pieces of ovarian tissue that remain in the pelvis can reattach to surrounding structures, regain blood supply, and begin functioning again. This means the tissue responds to hormonal signals, grows follicles, and produces estrogen, even though the ovaries were supposedly removed entirely.
The most common presentations are chronic pelvic pain, a pelvic mass (sometimes with pain, sometimes found incidentally), or both. Some women experience cyclical pain patterns similar to what they felt before surgery, which can be confusing and frustrating after an operation that was supposed to eliminate ovarian function altogether.
The Real Risks of Leaving It Untreated
The primary danger of ORS is not the remnant itself sitting quietly in the pelvis. It’s what happens when that tissue grows, forms cysts, or starts compressing nearby organs. Remnants can attach to and press against the ureters (the tubes connecting your kidneys to your bladder), the bowel, or the bladder wall. Ureteral obstruction is one of the more serious complications because it can silently damage kidney function if the blockage isn’t identified.
The ongoing hormone production also creates problems. If your ovaries were removed to treat a hormone-sensitive condition like endometriosis or certain cancers, a functioning remnant undermines the purpose of the original surgery. You may continue experiencing symptoms you thought were resolved, and conditions driven by estrogen can persist or worsen.
Cancer Risk
The possibility of malignant transformation is the most concerning long-term risk, though it remains rare. The true incidence of cancer developing in ovarian remnants can’t be precisely calculated from existing data because so few cases have been published. However, the connection to endometriosis raises the stakes considerably. Endometriosis is present in 30 to 50% of ORS patients who develop ovarian carcinoma, and endometriosis itself is a known risk factor for ovarian cancer. One review noted that endometriosis predisposes patients to ORS in the first place and is associated with roughly half of ORS patients who go on to develop ovarian cancer. This doesn’t mean cancer is likely for most people with ORS, but it does mean the remnant tissue carries the same malignant potential as a normal ovary.
Who Is Most at Risk for Developing ORS
ORS is more common in women whose original surgery was complicated by endometriosis, pelvic inflammatory disease, or dense adhesions (scar tissue binding organs together). These conditions make it harder for the surgeon to see and remove every piece of ovarian tissue cleanly. When the ovary is stuck to the pelvic wall or wrapped in scar tissue, small fragments are more easily left behind. Prior pelvic surgeries that created adhesions also increase the risk.
How ORS Is Diagnosed
If you’ve had both ovaries removed and start experiencing pelvic pain or a mass is found on imaging, ORS becomes a suspect. Blood tests can check for hormone levels that shouldn’t be present after ovary removal. Anti-Müllerian hormone (AMH) is one useful marker: a positive result indicates functional ovarian tissue is present somewhere in your body, while a negative result is consistent with complete ovary removal. Elevated estrogen levels in a woman who should be in surgical menopause also point toward a remnant.
Ultrasound and MRI are both effective at identifying pelvic masses associated with ORS. Both imaging methods perform well for characterizing ovarian-type lesions, with sensitivity reaching close to 100% in studies comparing the two. Your doctor may use one or both depending on what the initial exam reveals. The challenge isn’t usually seeing the mass but confirming it’s ovarian tissue rather than another type of growth.
Treatment Options and What to Expect
Surgery is the definitive treatment. The goal is to find and remove all remaining ovarian tissue, which sounds straightforward but is often technically difficult. The remnant is typically embedded in scar tissue and may be attached to the bowel, bladder, or ureter. This is why complication rates for this surgery are higher than for a standard ovary removal.
For open surgery (laparotomy), the rate of injury to the bladder, ureter, or bowel ranges from 3% to 33%, a wide range that reflects how variable the difficulty can be depending on how deeply embedded the remnant is. Minimally invasive surgery (laparoscopy) carries lower complication rates. One study of 69 laparoscopic procedures reported intraoperative complications in 5.8% of cases, with no ureteral injuries. Before surgery, you’ll typically be counseled about the possibility of needing bowel or bladder repair, ureteral surgery, or conversion from a minimally invasive approach to an open one if the remnant proves too difficult to remove safely through small incisions.
When surgery isn’t feasible or a patient prefers to avoid reoperation, hormonal suppression is an alternative. Medications that shut down the hormonal signals driving the remnant can reduce symptoms and shrink the tissue. Animal studies have shown that GnRH-blocking drugs reduce the estrogen activity of remnants and decrease follicle numbers. In practice, these medications manage symptoms but don’t eliminate the tissue. They’re generally considered a bridge or a fallback rather than a cure, since the remnant remains in place and can resume activity if the medication is stopped.
How Serious Is It Overall
For most people, ORS is a quality-of-life issue rather than an emergency. Chronic pelvic pain can be debilitating, and the frustration of dealing with symptoms after a surgery that was supposed to resolve them is real. The condition becomes genuinely dangerous in specific scenarios: when a remnant obstructs a ureter and threatens kidney function, when it grows large enough to compress the bowel, or in the uncommon event that malignant changes develop. The cancer risk, while not high in absolute terms, is not negligible either, particularly for women with a history of endometriosis.
The surgical fix is effective but carries its own risks because of where remnants tend to embed themselves. Most women who undergo removal by an experienced surgeon see resolution of their symptoms, though some require more than one operation if not all tissue is captured the first time.